|
⚲
|
| Keyboard |
| Naos Yaron
✚
|
|
|---|---|
| CIK # | 0001742727 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001742727] | |
| 4 | [0001742727] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Protalix BioTherapeutics Inc | |
| Naos Yaron |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protalix BioTherapeutics Inc PLX
Stock Option (Right to Buy) · derivative
|
2024-09-23 | Grant | 100,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2023-08-15 | Grant | 187,344 | ||
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2022-09-07 | Grant | 340,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2020-08-11 | Grant | 122,656 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2018-09-13 | Grant | 600,000 | $0.00 |